Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FEEVR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,027
Award facts
- Contract value 100% obligated
- $35,027.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $35,027.38 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose auto-injector pens on July 14, 2025, with completion targeted for July 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 comprehensive pharmaceutical prime vendor agreement running through December 2026 that enables the company to supply a broad range of medications and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains an extensive portfolio of federal medical procurement contracts predominantly with the Defense Logistics Agency and its Medical Supply Chain. The company's federal contracting demonstrates capability across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. This delivery order for Cosentyx—a biologic immunosuppressant used to treat autoimmune conditions—supports the Defense Health Agency and other military healthcare systems through DLA's established pharmaceutical supply chain infrastructure, consistent with the agency's role in providing medical logistics support across the Department of Defense.
Quick answers
Who was awarded contract SPE2DB25FEEVR?
SPE2DB25FEEVR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 14, 2025.
How much is contract SPE2DB25FEEVR worth?
The government has obligated $35,027 on SPE2DB25FEEVR.
Is contract SPE2DB25FEEVR an order under another contract?
Yes. SPE2DB25FEEVR is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB25FEEVR competed?
The extent of competition for SPE2DB25FEEVR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award